hsa_circ_0020093 suppresses ovarian cancer progression by modulating LRPPRC activity and miR-107/LATS2 signaling

Biology Direct

Table 1 Correlation between hsa_circ_0020093 expression and clinicopathologic factors of OC patients

Parameter		hsa_circ_0020093 (High, n = 22)	hsa_circ_0020093 (Low, n = 22)	P value
Age	≤ 50	10	7	0.353
	> 50	12	15	0.353
FIGO stage	I + II	14	7	0.035^*
	III + IV	8	15	0.035^*
Grade	Low	10	1	0.002^**
	High	12	21	0.002^**
Lymphatic metastasis	No	15	11	0.222
	Yes	7	11	0.222
Peritoneal implantation	No	12	4	0.012^*
	Yes	10	18	0.012^*
CA125 (U/mL)	< 35	7	0	0.004^**
	≥ 35	15	22	0.004^**

The bold numbers refer to the P value statistically significant, ** indicates that P＜0.01

ISSN: 1745-6150